TrialBMJ (Clinical research ed.)2025

Vernakalant versus procainamide for rapid cardioversion of patients with acute atrial fibrillation (RAFF4): randomised clinical trial.

Ian G Stiell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.